Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Faix RG, Laptook AR, Shankaran S, Eggleston B, Chowdhury D, Heyne RJ, Das A, Pedroza C, Tyson JE, Wusthoff C, Bonifacio SL, S?nchez PJ, Yoder BA, Laughon MM, Vasil DM, Van Meurs KP, Crawford MM, Higgins RD, Poindexter BB, Colaizy TT, Hamrick SEG, Chalak LF, Ohls RK, Hartley-McAndrew ME, Dysart K, D'Angio CT, Guillet R, Kicklighter SD, Carlo WA, Sokol GM, DeMauro SB, Hibbs AM, Cotten CM, Merhar SL, Bapat RV, Harmon HM, Sewell E, Winter S, Natarajan G, Mosquera R, Hintz SR, Maitre NL, Benninger KL, Peralta-Carcelen M, Hines AC, Duncan AF, Wilson-Costello DE, Trembath A, Malcolm WF, Walsh MC. Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial. JAMA Pediatr. 2025 Apr 01; 179(4):396-406.
-
Kayan Y, Delgado Almandoz JE, Copelan A, Matouk C, Chaudry MI, Altschul D, Essibayi MA, Goren O, Yim B, Tsappidi S, Zhang YJ, Hui FK, Samaniego EA, Gudino A, Siddiqui A, Jaikumar V, Puri AS, K?hn AL, Singh J, Ringer A, Hanel RA, De Toledo OF, Dabus G, Gooch MR, Sizdahkhani S, Field NC, Paul AR. Multicenter early United States feasibility study and periprocedural safety of LVIS EVO for the treatment of unruptured intracranial aneurysms. J Neurointerv Surg. 2025 Mar 17; 17(4):405-409.
-
Podder SK, Doermann A, Ibrahim G, Bowen M, Koeneman SH, Schleider C, Shindle K, Cowan SW, Yeo CJ, Hanna N. Impact of Disease Etiology and Indication for Colectomy on Postoperative Outcomes: NSQIP Colectomy-Targeted Database Study. J Am Coll Surg. 2025 Apr 01; 240(4):365-376.
-
Axeen S, Chen AJ, Lakdawalla DN, Masia N, Niyazov A, Arondekar B, Freedland SJ. Do trial benefits predict real-world gains in metastatic castration resistant prostate cancer. JNCI Cancer Spectr. 2025 Mar 03; 9(2).
-
Tos SM, Osama M, Mantziaris G, Hajikarimloo B, Adeeb N, Kandregula S, Dmytriw AA, Salim HA, Musmar B, Naamani KE, Ogilvy C, Kondziolka D, Abdelsalam A, Kumbhare D, Gummadi S, Ataoglu C, Erginoglu U, Essibayi MA, Keles A, Muram S, Sconzo D, Riina H, Rezai A, P?ppe J, Sen RD, Alwakaa O, Griessenauer CJ, Jabbour P, Tjoumakaris SI, Burkhardt JK, Starke RM, Baskaya M, Sekhar LN, Levitt MR, Altschul DJ, Haranhalli N, McAvoy M, Aslan A, Abushehab A, Swaid C, Abla A, Stapleton C, Koch M, Srinivasan VM, Chen PR, Blackburn S, Dannenbaum MJ, Choudhri O, Pukenas B, Orbach D, Smith E, M?hlenbruch M, Alaraj A, Aziz-Sultan A, Patel AB, Cuellar HH, Lawton M, Morcos J, Guthikonda B, Sheehan J. Spetzler-Martin grade I and II cerebral arteriovenous malformations: a propensity-score matched analysis of resection and stereotactic radiosurgery in adult patients. Neurosurg Rev. 2025 Feb 28; 48(1):276.
-
Adeeb N, Salim HA, Musmar B, Aslan A, Swaid C, Cuellar M, Dibas M, Cancelliere NM, Diestro JDB, Algin O, Ghozy S, Lay SV, Guenego A, Renieri L, Carnevale J, Saliou G, Mastorakos P, Naamani KE, Shotar E, M?hlenbruch M, Kral M, Chung C, Salem MM, Lylyk I, Foreman PM, Shaikh H, ?upancic V, Hafeez MU, Catapano J, Waqas M, Arslan M, Ergun O, Rabinov JD, Ren Y, Schirmer CM, Piano M, K?hn AL, Michelozzi C, Starke RM, Hassan A, Ogilvie M, Nguyen A, Jones J, Brinjikji W, Nawka MT, Psychogios M, Ulfert C, Pukenas B, Burkhardt JK, Huynh T, Martinez-Gutierrez JC, Essibayi MA, Sheth SA, Slawski D, Tawk R, Pulli B, Lubicz B, Panni P, Puri AS, Pero G, Raz E, Griessenauer CJ, Asadi H, Siddiqui A, Levy EI, Haranhalli N, Altschul D, Ducruet AF, Albuquerque FC, Regenhardt RW, Stapleton CJ, Kan P, Kalousek V, Lylyk P, Boddu S, Knopman J, Tjoumakaris SI, Jabbour PM, Claren?on F, Limbucci N, Yedavalli V, Wintermark M, Pereira VM, Patel AB, Cuellar-Saenz HH, Dmytriw AA. Incidence and predictors of Woven EndoBridge (WEB) shape modification following treatment of intracranial aneurysms in a large multicenter study. Neurosurg Rev. 2025 Feb 25; 48(1):265.
-
Havranek B, Loh R, Torre B, Redfield R, Halegoua-DeMarzio D. Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes. Sci Rep. 2025 Feb 10; 15(1):4947.
-
Zorowitz RD, Jacinto J, Ashford S, Beneteau M, Maisonobe P, Hannes C, Esquenazi A. Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice. J Rehabil Med. 2025 Feb 07; 57:jrm42605.
-
Schilder RJ, Rasco D, Sharma MR. An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors. Neoplasia. 2025 Mar; 61:101133.
-
Yildiz M, Schoenhoff F, Werdecker V, Nucera M, Mosbahi S, Zhao Y, Goel N, Berezowski M, Lawrence K, Kapoor S, Kreibich M, Berger T, Kletzer J, Bavaria J, Szeto WY, Siepe M, Czerny M, Desai ND. Revisiting ascending aortic resection in the elective valve-sparing root replacement: assessing the benefits and necessity of hemiarch replacement at three centres?. Eur J Cardiothorac Surg. 2025 Feb 04; 67(2).